Extremity Medical announced FDA 510(k) clearance for Axis Charcot, a comprehensive axial fixation system. First cases are scheduled for this month.
This product and the recently-released BioFuse next-gen live-cell bone graft are two of the company’s 16 products available globally to treat distal lower and upper extremities. Other 2017 launches include KinematX Total Wrist Arthroplasty, MTP fusion and Jones fracture systems.
Sources: Extremity Medical, LLC; ORTHOWORLD Inc.
Extremity Medical announced FDA 510(k) clearance for Axis Charcot, a comprehensive axial fixation system. First cases are scheduled for this month.
This product and the recently-released BioFuse next-gen live-cell bone graft are two of the company's 16...
Extremity Medical announced FDA 510(k) clearance for Axis Charcot, a comprehensive axial fixation system. First cases are scheduled for this month.
This product and the recently-released BioFuse next-gen live-cell bone graft are two of the company’s 16 products available globally to treat distal lower and upper extremities. Other 2017 launches include KinematX Total Wrist Arthroplasty, MTP fusion and Jones fracture systems.
Sources: Extremity Medical, LLC; ORTHOWORLD Inc.
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE
ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
Copy to clipboard 
